TransMedics Group, Inc. Share Price & Technical Analysis
TMDX · $72.42 (+3.92%)
Healthcare / Medical Devices
$72.42
+3.92%
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic cond…
Price chart
Seasonality
Jun has 5 positive and 0 negative years (last 5 years shown)
5% return in Jun, 11% avg return in past 3 year Jun month.
-41% return in 2026, 52% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 8% | 9% | -29% | -1% | -33% | 5% | – | – | – | – | – | – | -41% |
| 25 | 6% | 17% | -12% | 39% | 38% | 6% | -11% | -2% | 0% | 18% | 14% | -16% | 97% |
| 24 | 11% | -4% | -11% | 27% | 24% | 11% | -6% | 2% | -6% | -47% | 5% | -28% | -22% |
| 23 | 1% | 28% | -5% | 5% | -8% | 16% | 10% | -29% | -16% | -31% | 103% | 6% | 80% |
| 22 | -17% | 17% | 45% | -23% | 38% | 8% | 29% | 31% | -19% | 16% | 26% | -1% | 150% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.38B
P/E ratio
15.74
52W high
$156.0
52W low
$60.10
Volume
6,18,662
Beta
2.06
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is TransMedics Group, Inc. share price today?
- TransMedics Group, Inc. (TMDX) last traded around $72.42 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TMDX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TMDX. Download the app for real-time alerts.
- How can I analyze TransMedics Group, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.